# FHIR Standards

## Standard Terminologies Used

### LOINC Codes

| Code | Display Name | Usage |
| :--- | :--- | :--- |
| **69548-6** | Genetic variant assessment | Variant Observation resources |
| **81247-9** | Master HL7 genetic variant reporting panel | DiagnosticReport resource |
| **81290-9** | Genomic DNA change (gHGVS) | Genomic changes |
| **48005-3** | Amino acid change (pHGVS) | Protein changes |
| **48018-6** | Gene studied [ID] | Affected gene |
| **51961-1** | Genetic variation's effect on drug efficacy | Linking variant to a drug |
| **53037-8** | Genetic variation clinical significance [Imp] | WHO classification |
| **82121-5** | Allelic read depth | Sequencing depth |
| **614-8** | Mycobacterial strain [Type] in Isolate by Mycobacterial subtyping | Lineage classification |

### SNOMED CT Codes

**Drugs**
| Code | Display Name |
| :--- | :--- |
| **29175007** | Product containing rifampicin |
| **81335000** | Product containing isoniazid |
| **13592004** | Product containing pyrazinamide |
| **24450004** | Product containing ethambutol |
| **40877002** | Product containing streptomycin |
| **1010205001** | Medicinal product containing fluoroquinolone |
| **96087006** | Product containing levofloxacin |
| **371296007** | Product containing moxifloxacin |
| **48836000** | Product containing amikacin |
| **71451001** | Product containing kanamycin |
| **14170004** | Product containing capreomycin |
| **414148003** | Product containing ethionamide |
| **125695009** | Product containing linezolid |
| **714087008** | Product containing bedaquiline |
| **72924009** | Product containing clofazimine |

### Sequence Ontology (SO)

| Code | Display Name |
| :--- | :--- |
| **SO:0001583** | missense_variant |
| **SO:0001819** | synonymous_variant |
| **SO:0001587** | stop_gained |
| **SO:0001578** | stop_lost |
| **SO:0001589** | frameshift_variant |
| **SO:0001821** | inframe_insertion |
| **SO:0001822** | inframe_deletion |
| **SO:0001629** | splice_site_variant |
| **SO:0001631** | upstream_gene_variant |
| **SO:0001632** | downstream_gene_variant |
| **SO:0001628** | intergenic_variant |
| **SO:0001627** | intron_variant |
| **SO:0001623** | 5_prime_UTR_variant |
| **SO:0001624** | 3_prime_UTR_variant |
| **SO:0002012** | start_lost |
| **SO:0001567** | stop_retained_variant |
| **SO:0001818** | protein_altering_variant |
| **SO:0001580** | coding_sequence_variant |
| **SO:0001619** | non_coding_transcript_variant |
| **SO:0001566** | regulatory_region_variant |

**WHO Classification**
| Code | Display Name | Usage |
| :--- | :--- | :--- |
| **LA26333-7** | Uncertain significance | LOINC |
| **SP000478** | Assoc w R | Custom code |
| **SP000479** | Assoc w R - Interim | Custom code |
| **SP000480** | Not assoc w R - Interim | Custom code |
| **SP000481** | Not assoc w R | Custom code |

**Clinical & Specimen**
| Code | Display Name | Usage |
| :--- | :--- | :--- |
| **415345001** | Rifampicin resistant tuberculosis | Diagnostic conclusion |
| **414546009** | Isoniazid resistant tuberculosis | Diagnostic conclusion |
| **423092005** | Multidrug resistant tuberculosis | Diagnostic conclusion |
| **OV000435** | Pre-XDR-TB | Diagnostic conclusion |
| **710106005** | Extensively drug resistant tuberculosis | Diagnostic conclusion |
